AEG-POWER-SOLUTIONS
AEG Power Solutions (FWB:3W9K), a global provider of power electronic systems and solutions for industrial power supplies and renewable energy applications, today announced that it has been selected to provide 25 UPS systems for the Tempa Rossa onshore oilfield in Italy (more info on Tempa Rossa: www.it.total.com ).
The main engineering, procurement and construction (EPC) contractor for the oil and gas central processing facility at Tempa Rossa is Tecnimont S.p.A., main subsidiary of Maire Tecnimont Group, industrial leader in the hydrocarbon industry with headquarters in Milan. Tecnimont has chosen AEG Power Solutions to provide the complete power supply solutions of the site, consisting of 4 DC UPS systems, 15 AC UPS systems and 6 combined AC and DC systems.
Tecnimont selected a combination of AEG Power Solutions’ Protect 8 UPS, its Protect 8 inverter, and the Protect RCS rectifier, which was specified as the TPRe (three-phase rectifier) model. AEG Power Solutions has also provided customized bypass panels, as well as Ni-Cd batteries and moulded case circuit breaker (MCCB) boxes for battery protection.
AEG Power Solutions worked closely with Tecnimont during the technical project analysis and clarification, helping to finalize important points of the project and propose possible solutions. AEG PS battery expertise made a major difference allowing the final customer to save money on batteries costs and maintenance.
“Having started to build a relationship with AEG Power Solutions during the procurement process, we could see that they had the technical excellence and experience required – as well as the best product range,” says Paolo Mondo, Maire Tecnimont Group Procurement VP. “We were confident that AEG Power Solutions was the right choice to provide these mission-critical UPS systems.”
“Tempa Rossa is a major project, that places tough demands on the UPS and other electrical systems to operate in a harsh environment,” says Alberto Dall'Asta, Sales Director in Italy. “We are delighted that Tecnimont has recognized how our industrial product range can meet its requirements for a reliable, flexible solution.”
Total and its partners Shell and Mitsui are currently developing Tempa Rossa, one of the biggest ever oil and gas projects in Italy; it is expected in 2016 to produce 50,000 barrels a day of oil, as well as 230,000m³/d of natural gas and 240 tons/d of liquefied petroleum gas (LPG) and 80 tons/d of sulfur.
No. No. No.
Visit us from 10th to 13th November at ADIPEC in Abu Dhabi, UAE. At booth 8273 in hall 8, AEG Power Solutions will be exhibiting latest uninterruptible power supplies (UPS) systems and other AC and DC power solutions for the demanding oil and gas industry.
About AEG Power Solutions
AEG Power Solutions (AEG PS) Group
is a global provider of power electronics systems and solutions for all
industrial and demanding commercial power requirements offering one of
the most comprehensive product and service portfolios in the area of
uninterruptible power supply and power management.
Thanks to its distinctive expertise bridging both AC and DC power technologies and spanning the worlds of both conventional and renewable energy, the company creates innovative solutions for next generation distributed power generation.
AEG Power Solutions Group is the sole subsidiary of the holding company 3W Power S.A. (WKN A114Z9) / ISINLU1072910919), based in Luxembourg. The Group is headquartered in Zwanenburg in the Netherlands. The shares of 3W Power are admitted to trading on Frankfurt Stock Exchange (ticker symbol: 3W9K).
For more information, visit www.aegps.com .
This communication does not constitute an offer or the solicitation of an offer to buy, sell or exchange any securities of 3W Power. This communication contains forward-looking statements which include, inter alia, statements expressing our expectations, intentions, projections, estimates, and assumptions. These forward-looking statements are based on the reasonable evaluation and opinion of the management but are subject to risks and uncertainties which are beyond the control of 3W Power and, as a general rule, difficult to predict. The management and the company cannot and do not, under any circumstances, guarantee future results or performance of 3W Power and the actual results of 3W Power may materially differ from the information expressed or implied in the forward-looking statements. As a result, investors are cautioned against relying on the forward-looking statements contained herein as a basis for their investment decisions regarding 3W Power.
3W Power undertakes no obligation to update or revise any forward-looking statement contained herein.
AEG is a registered trademark used under license from AB Electrolux
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20141106005813/en/
Contact:
Claire Pairault
Corporate Communications
AEG Power Solutions
Mobile:
+33-6-19-60-91-64
Email: claire.pairault@aegps.com
or
Contact
for Editors
Gerlinde Knoepfle
embedded PR
Phone +49
(0)89/64913634-12
Cell +49 (0)160/95127238
gk@embedded-pr.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum